Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia.

Emamian ES, Hall D, Birnbaum MJ, Karayiorgou M, Gogos JA.

Nat Genet. 2004 Feb;36(2):131-7. Epub 2004 Jan 25.

PMID:
14745448
2.

Failure to support a genetic contribution of AKT1 polymorphisms and altered AKT signaling in schizophrenia.

Ide M, Ohnishi T, Murayama M, Matsumoto I, Yamada K, Iwayama Y, Dedova I, Toyota T, Asada T, Takashima A, Yoshikawa T.

J Neurochem. 2006 Oct;99(1):277-87.

3.
4.

Paliperidone protects SK-N-SH cells against glutamate toxicity via Akt1/GSK3β signaling pathway.

Peng L, Zhang X, Cui X, Zhu D, Wu J, Sun D, Yue Q, Li Z, Liu H, Li G, Zhang J, Xu H, Liu F, Qin C, Li M, Sun J.

Schizophr Res. 2014 Aug;157(1-3):120-7. doi: 10.1016/j.schres.2014.05.037. Epub 2014 Jun 22.

PMID:
24962437
5.

DRD2/AKT1 interaction on D2 c-AMP independent signaling, attentional processing, and response to olanzapine treatment in schizophrenia.

Blasi G, Napolitano F, Ursini G, Taurisano P, Romano R, Caforio G, Fazio L, Gelao B, Di Giorgio A, Iacovelli L, Sinibaldi L, Popolizio T, Usiello A, Bertolino A.

Proc Natl Acad Sci U S A. 2011 Jan 18;108(3):1158-63. doi: 10.1073/pnas.1013535108. Epub 2010 Dec 27.

6.

Regulation of Akt and glycogen synthase kinase-3 beta phosphorylation by sodium valproate and lithium.

De Sarno P, Li X, Jope RS.

Neuropharmacology. 2002 Dec;43(7):1158-64.

PMID:
12504922
7.

Association of AKT1 haplotype with the risk of schizophrenia in Iranian population.

Bajestan SN, Sabouri AH, Nakamura M, Takashima H, Keikhaee MR, Behdani F, Fayyazi MR, Sargolzaee MR, Bajestan MN, Sabouri Z, Khayami E, Haghighi S, Hashemi SB, Eiraku N, Tufani H, Najmabadi H, Arimura K, Sano A, Osame M.

Am J Med Genet B Neuropsychiatr Genet. 2006 Jun 5;141B(4):383-6.

PMID:
16583435
8.

AKT/GSK3 signaling pathway and schizophrenia.

Emamian ES.

Front Mol Neurosci. 2012 Mar 15;5:33. doi: 10.3389/fnmol.2012.00033. eCollection 2012.

9.

Altered GSK3β signaling in an infection-based mouse model of developmental neuropsychiatric disease.

Willi R, Harmeier A, Giovanoli S, Meyer U.

Neuropharmacology. 2013 Oct;73:56-65. doi: 10.1016/j.neuropharm.2013.05.012. Epub 2013 May 21.

PMID:
23707483
10.

Possible involvement of post-dopamine D2 receptor signalling components in the pathophysiology of schizophrenia.

Amar S, Shaltiel G, Mann L, Shamir A, Dean B, Scarr E, Bersudsky Y, Belmaker RH, Agam G.

Int J Neuropsychopharmacol. 2008 Mar;11(2):197-205. Epub 2007 Aug 6.

PMID:
17681085
11.

Glycogen-Synthase Kinase3beta/beta-catenin axis promotes angiogenesis through activation of vascular endothelial growth factor signaling in endothelial cells.

Skurk C, Maatz H, Rocnik E, Bialik A, Force T, Walsh K.

Circ Res. 2005 Feb 18;96(3):308-18. Epub 2005 Jan 20.

12.

P2 purinergic receptors signal to glycogen synthase kinase-3beta in astrocytes.

Neary JT, Kang Y.

J Neurosci Res. 2006 Aug 15;84(3):515-24.

PMID:
16810687
13.
14.

Regulation of glycogen synthase kinase-3beta by products of lipid peroxidation in human neuroblastoma cells.

Dozza B, Smith MA, Perry G, Tabaton M, Strocchi P.

J Neurochem. 2004 Jun;89(5):1224-32.

15.

Role that phosphorylation of GSK3 plays in insulin and Wnt signalling defined by knockin analysis.

McManus EJ, Sakamoto K, Armit LJ, Ronaldson L, Shpiro N, Marquez R, Alessi DR.

EMBO J. 2005 Apr 20;24(8):1571-83. Epub 2005 Mar 24.

16.

Glycogen synthase kinase 3beta (GSK3beta) mediates 6-hydroxydopamine-induced neuronal death.

Chen G, Bower KA, Ma C, Fang S, Thiele CJ, Luo J.

FASEB J. 2004 Jul;18(10):1162-4. Epub 2004 May 7.

PMID:
15132987
18.

Acute selective glycogen synthase kinase-3 inhibition enhances insulin signaling in prediabetic insulin-resistant rat skeletal muscle.

Dokken BB, Sloniger JA, Henriksen EJ.

Am J Physiol Endocrinol Metab. 2005 Jun;288(6):E1188-94. Epub 2005 Jan 25.

19.

UCN-01 alters phosphorylation of Akt and GSK3beta and induces apoptosis in six independent human neuroblastoma cell lines.

Shankar SL, Krupski M, Parashar B, Okwuaka C, O'Guin K, Mani S, Shafit-Zagardo B.

J Neurochem. 2004 Aug;90(3):702-11.

20.

Dysregulation of glycogen synthase kinase-3beta signaling in hepatocellular carcinoma cells.

Desbois-Mouthon C, Blivet-Van Eggelpoël MJ, Beurel E, Boissan M, Delélo R, Cadoret A, Capeau J.

Hepatology. 2002 Dec;36(6):1528-36.

PMID:
12447879

Supplemental Content

Support Center